ELV vs. IDXX: Elevance Health vs. IDEXX Laboratories Stock Comparison

Company Profile

Elevance Health (ELV) and IDEXX Laboratories (IDXX) both fall under the Health Care Equipment & Services industry group, but ELV is classified in Health Care Providers & Services while IDXX is classified in Health Care Equipment & Supplies.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while Elevance Health (ELV) is defensive at 0.61 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

IDEXX Laboratories (IDXX) at 68.93% clears its industry range for ROE, a sharper capital-efficiency signal than Elevance Health (ELV) at 11.48%, which is closer to a typical peer reading.

IDEXX Laboratories (IDXX) at 25.36% retains a top-quartile share of revenue as profit, ahead of Elevance Health (ELV) at 2.55%, which keeps about the industry-typical share.

IDEXX Laboratories (IDXX) at 33.14% operates in the top operating margin quartile, ahead of Elevance Health (ELV) at 4.22%, which runs around its industry’s norm.

Profitability Metrics

Growth

Both Elevance Health (ELV) at 12.62% and IDEXX Laboratories (IDXX) at 10.42% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Both Elevance Health (ELV) at -1.83% and IDEXX Laboratories (IDXX) at 22.59% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Growth Metrics

Financial Strength

Elevance Health (ELV) at 1.47 keeps current ratio within its industry’s typical mid-range, while IDEXX Laboratories (IDXX) at 1.19 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for IDXX.

Both Elevance Health (ELV) at 0.69 and IDEXX Laboratories (IDXX) at 0.52 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

IDEXX Laboratories (IDXX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Elevance Health (ELV) reports a yield of 1.59%, ranking against industry peers normally.

IDEXX Laboratories (IDXX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Elevance Health (ELV) reports a payout of 29.17%, ranking against industry peers normally.

Dividend Metrics

Valuation

Elevance Health (ELV) at 18.07 sits in the cheaper P/E ratio quartile, while IDEXX Laboratories (IDXX) at 45.56 is closer to its industry’s usual earnings multiple — a discount for ELV, though growth and earnings durability still matter.

Elevance Health (ELV) at 0.46 sits in the cheaper P/S ratio quartile while IDEXX Laboratories (IDXX) at 11.42 prices above its industry range — a wide gap in sales valuation between them.

Elevance Health (ELV) at 2.06 sits near its industry’s typical P/B ratio, while IDEXX Laboratories (IDXX) at 28.50 prices above its benchmark range — IDXX looks rich relative to book.

Valuation Metrics